Use of dipeptidyl peptidase‐4 inhibitors and the risk of arthralgia: Population‐based cohort and nested case–control studies

Pharmacoepidemiology and Drug Safety ◽

10.1002/pds.4733 ◽

2019 ◽

Vol 28 (4) ◽

pp. 500-506

Author(s):

Chen‐Yu Wang ◽

Shau‐Huai Fu ◽

Rong‐Sen Yang ◽

Fei‐Yuan Hsiao

Keyword(s):

Dipeptidyl Peptidase ◽

Population Based ◽

Case Control ◽

Case Control Studies ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Nested Case Control

Download Full-text

Association Between Use of Dipeptidyl Peptidase-4 Inhibitors and the Risk of Acute Kidney Injury: A Nested Case-Control Study

Mayo Clinic Proceedings ◽

10.1016/j.mayocp.2016.03.022 ◽

2016 ◽

Vol 91 (7) ◽

pp. 867-872 ◽

Author(s):

Chia-Jen Shih ◽

Yi-Jung Lee ◽

Yuan-Hao Lo ◽

Shu-Chen Kuo ◽

Shuo-Ming Ou ◽

...

Keyword(s):

Acute Kidney Injury ◽

Case Control Study ◽

Kidney Injury ◽

Dipeptidyl Peptidase ◽

Case Control ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Nested Case Control ◽

Download Full-text

Acute Pancreatitis in Patients with Type 2 Diabetes Mellitus Treated with Dipeptidyl Peptidase-4 Inhibitors: A Population-Based Nested Case-Control Study

Drug Safety ◽

10.1007/s40264-014-0171-x ◽

2014 ◽

Vol 37 (7) ◽

pp. 521-528 ◽

Author(s):

Hsin-Chun Chou ◽

Wen-Wen Chen ◽

Fei-Yuan Hsiao

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Case Control Study ◽

Population Based ◽

Case Control ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Nested Case Control ◽

Download Full-text

Exposure to dipeptidyl‐peptidase‐4 inhibitors and COVID ‐19 among people with type 2 diabetes: A case‐control study

Diabetes Obesity and Metabolism ◽

10.1111/dom.14097 ◽

2020 ◽

Vol 22 (10) ◽

pp. 1946-1950 ◽

Author(s):

Gian Paolo Fadini ◽

Mario Luca Morieri ◽

Enrico Longato ◽

Benedetta Maria Bonora ◽

Silvia Pinelli ◽

...

Keyword(s):

Type 2 Diabetes ◽

Case Control Study ◽

Dipeptidyl Peptidase ◽

Case Control ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Download Full-text

Association between dipeptidyl peptidase-4 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: A population-based cohort study

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2020.108546 ◽

2021 ◽

Vol 171 ◽

pp. 108546

Author(s):

Chen-Yi Wu ◽

Chun-Ying Wu ◽

Chung-Pin Li ◽

Yiing-Jenq Chou ◽

Yi-Hsian Lin ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Bullous Pemphigoid ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Effectiveness and safety of sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors in older adults with type 2 diabetes: A nationwide population‐based study

Diabetes Obesity and Metabolism ◽

10.1111/dom.14261 ◽

2020 ◽

Author(s):

Seung Jin Han ◽

Kyoung Hwa Ha ◽

Nami Lee ◽

Dae Jung Kim

Keyword(s):

Type 2 Diabetes ◽

Older Adults ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Population Based Study ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

P113 Risk of osteoporosis and fragility fractures in asthma due to oral and inhaled corticosteroids: Two population-based nested case-control studies

10.1136/thorax-2020-btsabstracts.258 ◽

2021 ◽

Author(s):

C Chalitsios ◽

D Shaw ◽

T McKeever

Keyword(s):

Inhaled Corticosteroids ◽

Fragility Fractures ◽

Population Based ◽

Case Control ◽

Case Control Studies ◽

Nested Case Control

Download Full-text

Independent risk factors for injury in pre-school children: three population-based nested case-control studies using routine primary care data

Injury Prevention ◽

10.1136/injuryprev-2012-040590w.24 ◽

2012 ◽

Vol 18 (Suppl 1) ◽

pp. A231.3-A231

Author(s):

D Kendrick ◽

E Orton ◽

J West ◽

L Tata

Keyword(s):

Risk Factors ◽

Primary Care ◽

School Children ◽

Population Based ◽

Case Control ◽

Case Control Studies ◽

Primary Care Data ◽

Independent Risk Factors ◽

Nested Case Control

Download Full-text

Comment on “Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case control study”

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2018.06.043 ◽

2018 ◽

Vol 79 (6) ◽

pp. e111-e112 ◽

Author(s):

Khalaf Kridin

Keyword(s):

Bullous Pemphigoid ◽

Case Control Study ◽

Dipeptidyl Peptidase ◽

Case Control ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Download Full-text

Reply to: “Comment on ‘Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case control study’”

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2018.06.042 ◽

2018 ◽

Vol 79 (6) ◽

pp. e113-e114 ◽

Author(s):

Outi Varpuluoma ◽

Laura Huilaja ◽

Kaisa Tasanen

Keyword(s):

Bullous Pemphigoid ◽

Case Control Study ◽

Dipeptidyl Peptidase ◽

Case Control ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Download Full-text

Dipeptidyl peptidase‐4 inhibitors lower the risk of autoimmune disease in patients with type 2 diabetes mellitus: A nationwide population‐based cohort study

British Journal of Clinical Pharmacology ◽

10.1111/bcp.13955 ◽

2019 ◽

Vol 85 (8) ◽

pp. 1719-1727 ◽

Author(s):

Jong‐Mi Seong ◽

Jeong Yee ◽

Hye Sun Gwak

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cohort Study ◽

Autoimmune Disease ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text